1型糖尿病的诊断与胰岛素治疗（2023年更新）
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)].
作者信息
Lechleitner Monika, Kaser Susanne, Hoppichler Friedrich, Roden Michael, Weitgasser Raimund, Ludvik Bernhard, Fasching Peter, Winhofer Yvonne, Kautzky-Willer Alexandra, Schernthaner Guntram, Prager Rudolf, Wascher Thomas C, Clodi Martin
机构信息
Avomed - Arbeitskreis für Vorsorgemedizin zbd Gesundheitsförderung in Tirol, Innsbruck, Österreich.
Department für Innere Medizin 1, Medizinische Universität Innsbruck, Innsbruck, Österreich.
出版信息
Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):98-105. doi: 10.1007/s00508-023-02182-8. Epub 2023 Apr 20.
Abstract
This guideline summarizes diagnosis of type 1 diabetes, including accompanying autoimmune disorders, insulin therapy regimens and glycemic target values.
摘要
本指南总结了1型糖尿病的诊断，包括伴发的自身免疫性疾病、胰岛素治疗方案和血糖目标值。
相似文献
1
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)].1型糖尿病的诊断与胰岛素治疗（2023年更新）
Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):98-105. doi: 10.1007/s00508-023-02182-8. Epub 2023 Apr 20.
2
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2019)].1型糖尿病的诊断与胰岛素治疗（2019年更新）
Wien Klin Wochenschr. 2019 May;131(Suppl 1):77-84. doi: 10.1007/s00508-019-1493-6.
3
[Type 1 diabetes mellitus: pathogenesis, symptoms and therapy].1型糖尿病：发病机制、症状与治疗
Orv Hetil. 2010 Mar 28;151(13):533-9. doi: 10.1556/OH.2010.28836.
4
Optimizing glycemic control with insulin glargine.使用甘精胰岛素优化血糖控制。
Diabetes Technol Ther. 2003;5(3):471-3. doi: 10.1089/152091503765692009.
5
[Differential diagnosis of insulin- and noninsulin-dependent diabetes mellitus--are there therapeutic implications?].[胰岛素依赖型和非胰岛素依赖型糖尿病的鉴别诊断——是否具有治疗意义？]
Praxis (Bern 1994). 1994 Dec 13;83(50):1406-9.
6
Clinical considerations when adding a sodium-glucose co-transporter-2 inhibitor to insulin therapy in patients with diabetes mellitus.糖尿病患者胰岛素治疗中加用钠-葡萄糖协同转运蛋白2抑制剂时的临床考量
Hong Kong Med J. 2019 Aug;25(4):312-319. doi: 10.12809/hkmj197802.
7
[Value of continuous glucose monitoring in type 2 diabetic patients].[持续葡萄糖监测在 2 型糖尿病患者中的价值]
Rev Med Suisse. 2017 May 31;13(565):1140-1144.
8
[New-onset type 1 diabetes: what to do, differential diagnosis and prevention].[新发1型糖尿病：应对措施、鉴别诊断与预防]
MMW Fortschr Med. 2011 May 19;153(20):45-7. doi: 10.1007/BF03368389.
9
Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.速效胰岛素类似物对1型和2型糖尿病患者总体血糖控制的影响。
Diabetes Technol Ther. 2003;5(1):57-66. doi: 10.1089/152091503763816472.
10
Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes.持续血糖监测在需胰岛素治疗的糖尿病患者中的作用
Diabetes Technol Ther. 2018 Jun;20(S2):S242-S249. doi: 10.1089/dia.2018.0100.
引用本文的文献
1
[Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association].[立场文件：奥地利视角下开源技术在糖尿病患者治疗中的应用：奥地利糖尿病协会技术委员会]
Wien Klin Wochenschr. 2024 Jul;136(Suppl 9):467-477. doi: 10.1007/s00508-024-02400-x. Epub 2024 Aug 28.
本文引用的文献
1
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).《成人 1 型糖尿病管理：美国糖尿病协会 (ADA) 与欧洲糖尿病研究协会 (EASD) 的共识报告》
Diabetes Care. 2021 Nov;44(11):2589-2625. doi: 10.2337/dci21-0043. Epub 2021 Sep 30.
2
Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.超短效赖脯胰岛素降低餐后血糖，与其他速效胰岛素类似物相比，更接近正常生理血糖反应：一项 1 期随机、交叉研究。
Diabetes Obes Metab. 2020 Oct;22(10):1789-1798. doi: 10.1111/dom.14094. Epub 2020 Jun 18.
3
Autoimmunity to tetraspanin-7 in type 1 diabetes.1 型糖尿病中对四跨膜蛋白 7 的自身免疫。
Med Microbiol Immunol. 2020 Aug;209(4):437-445. doi: 10.1007/s00430-020-00674-2. Epub 2020 Apr 20.
4
Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis.全球1型糖尿病的患病率和发病率：一项系统评价与荟萃分析。
Health Promot Perspect. 2020 Mar 30;10(2):98-115. doi: 10.34172/hpp.2020.18. eCollection 2020.
5
Biosimilars and Novel Insulins.生物类似药和新型胰岛素。
Am J Ther. 2020 Jan/Feb;27(1):e52-e61. doi: 10.1097/MJT.0000000000001079.
6
Clinical guidelines for type 1 diabetes mellitus with an emphasis on older adults: an Executive Summary.1 型糖尿病临床指南，重点关注老年人：执行摘要。
Diabet Med. 2020 Jan;37(1):53-70. doi: 10.1111/dme.14135. Epub 2019 Sep 23.
7
Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors.附带损伤：检查点抑制剂诱导的胰岛素依赖型糖尿病。
Diabetes. 2018 Aug;67(8):1471-1480. doi: 10.2337/dbi18-0002. Epub 2018 Jun 24.
8
Type 1 diabetes.1 型糖尿病。
Lancet. 2018 Jun 16;391(10138):2449-2462. doi: 10.1016/S0140-6736(18)31320-5.
9
Diabetes in Childhood and Adolescence.儿童和青少年糖尿病。
Dtsch Arztebl Int. 2018 Mar 2;115(9):146-156. doi: 10.3238/arztebl.2018.0146.
10
Greater early postprandial suppression of endogenous glucose production and higher initial glucose disappearance is achieved with fast-acting insulin aspart compared with insulin aspart.与门冬胰岛素相比，速效门冬胰岛素可实现更大的内源性葡萄糖生成早期餐后抑制和更高的初始葡萄糖清除率。
Diabetes Obes Metab. 2018 Jul;20(7):1615-1622. doi: 10.1111/dom.13270. Epub 2018 Mar 30.
Zotero 插件